Kenneth Kalunian, MD, FACR

UC San Diego
La Jolla, CA, United States

Adult rheumatologist/clinical scientist with interests in SLE and OA.

Presentation(s):

• 12S167: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes I: Biomarkers (0847–0852)

  Sunday, November 12, 2023
  4:00 PM – 5:30 PM PT

  Disclosure(s): Artiva Biosciences: Consultant (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Otsuka: Consultant (Ongoing); RemeGen: Consultant (Ongoing)

• 1496: Clinical Safety and Efficacy Results from EQUALISE Type B: A Phase 1b Open-label Clinical Study of Itolizumab, a Novel anti-CD6 Therapy, in Subjects with Active Proliferative Lupus Nephritis

  Monday, November 13, 2023
  9:00 AM – 11:00 AM PT

  Disclosure(s): Artiva Biosciences: Consultant (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Otsuka: Consultant (Ongoing); RemeGen: Consultant (Ongoing)